Biohub’s New Evolutionary Scale Models Advance AI-Driven Protein Engineering For Cancer And Immune Research

Zuckerberg and Chan’s Biohub launched open-source AI protein models capable of predicting and designing proteins, with early results targeting cancer and immune-related diseases. The post Biohub’s New Evolutionary Scale Models Advance AI-Driven Protein Engineering For Cancer And Immune Research appeared first on Metaverse Post.